J9185 Fludarabine phosphate injection
Also known as: fludarabine, Fludara
Intravenous injection of fludarabine phosphate, a purine nucleoside analog chemotherapy.
In Plain Language
DNA-inhibiting cancer drug; lymphoma and leukemia treatment
Clinical Context
Used for chronic lymphocytic leukemia and indolent lymphomas, inhibiting DNA synthesis and repair.
RVU Information
CPT J9185 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9185?
CPT J9185 (Fludarabine phosphate injection) is a J Codes (Drugs) code. Intravenous injection of fludarabine phosphate, a purine nucleoside analog chemotherapy.
How is J9185 administered?
CPT J9185 is administered by a healthcare provider, typically via injection or infusion. Used for chronic lymphocytic leukemia and indolent lymphomas, inhibiting DNA synthesis and repair. It is used by Hematology/Oncology, Medical Oncology.
When is CPT J9185 used?
Used for chronic lymphocytic leukemia and indolent lymphomas, inhibiting DNA synthesis and repair.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.